Veru ranked as one of the fastest-growing companies in north america on the 2021 deloitte technology fast 500

-- veru is a late-stage clinical development biopharmaceutical company developing drugs for the treatment of breast cancer, prostate cancer, and covid-19, large premium global markets–

VERU Ratings Summary

VERU Quant Ranking